Source: centralcharts

Marker Therapeutics received $9.5M in Grant Funding

Read full article »

Marker Therapeutics's Competitors | Marker Therapeutics's News | Marker Therapeutics's Financials

Followers on Owler

401

Annual Revenue

$5.0-25M

Employees

1-25

Juan F. Vera's photo - CEO of Marker Therapeutics

CEO

Juan F. Vera

CEO Approval Rating

82/100

Marker Therapeutics is a Texas-based biotechnology firm that develops and commercializes novel T-cell therapies for the treatment of cancer.